NOSEALIGN Trademark

Trademark Overview


On Sunday, March 28, 2021, a trademark application was filed for NOSEALIGN with the United States Patent and Trademark Office. The USPTO has given the NOSEALIGN trademark a serial number of 90607934. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Cleftalign Inc.. The NOSEALIGN trademark is filed in the Medical Instrument Products category with the following description:

Nasal stent, namely, nasal dilator
nosealign

General Information


Serial Number90607934
Word MarkNOSEALIGN
Filing DateSunday, March 28, 2021
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7289222
Registration DateTuesday, January 23, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkNOSE ALIGN
Goods and ServicesNasal stent, namely, nasal dilator

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, July 3, 2021
Primary Code010
First Use Anywhere DateMonday, March 1, 2021
First Use In Commerce DateMonday, September 26, 2022

Trademark Owner History


Party NameCleftalign Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Party NameCleftalign Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, November 14, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, October 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 11, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 10, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, July 10, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 13, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Thursday, April 13, 2023SUBSEQUENT FINAL EMAILED
Thursday, April 13, 2023SUBSEQUENT FINAL REFUSAL WRITTEN
Friday, March 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, December 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2022NON-FINAL ACTION E-MAILED
Monday, December 19, 2022NON-FINAL ACTION WRITTEN
Monday, December 19, 2022USE AMENDMENT ACCEPTED
Wednesday, December 7, 2022AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, December 7, 2022USE AMENDMENT FILED
Tuesday, December 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 5, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, December 5, 2022TEAS AMENDMENT OF USE RECEIVED
Monday, June 6, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 6, 2022FINAL REFUSAL E-MAILED
Monday, June 6, 2022FINAL REFUSAL WRITTEN
Monday, May 16, 2022ASSIGNED TO EXAMINER
Thursday, May 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NON-FINAL ACTION WRITTEN
Friday, November 5, 2021ASSIGNED TO EXAMINER
Saturday, July 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 31, 2021NEW APPLICATION ENTERED

Related Keywords


nosealign nasal dilator stent namely